XML 35 R23.htm IDEA: XBRL DOCUMENT

Other Financial Statement Information (Tables)

6 Months Ended

Jun. 30, 2024

Other Financial Statement Information [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


		June 30, 2024				December 31, 2023
Prepaid clinical trial costs		$	4,371			$	5,273
Interest income receivable			1,960				512
Prepaid insurance			1,247				597
Prepaid drug manufacturing costs			873				2,578
Prepaid commercial planning			574				789
Prepaid software license fees			393				237
Prepaid rent			274				257
Prepaid professional services fees			239				198
Other			429				866
Total prepaid expenses and other current assets		$	10,360			$	11,307

Schedule of Accrued Expenses And Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


		June 30, 2024				December 31, 2023
Accrued clinical and drug manufacturing expenses		$	8,131			$	2,213
Accrued payroll			2,582				3,932
Related party payable			105				1,926
Other accrued expenses			820				678
Total accrued expenses and other current liabilities		$	11,638			$	8,749